Patient Impact
The detrimental impact of poor sleep quality on the daytime symptoms and health-related quality of life of women with breast cancer has been suggested in several studies. Poor subjective sleep quality was significantly associated with poor functional well-being, greater fatigue intensity, greater disruptions in social interactions, and lower positive states of mind in women prior to adjunct therapy for breast cancer (Vargas et al., 2010 Findings: Poor subjective sleep quality was predicted by depressed mood (p < 0.00005). All mean objective sleep characteristics were similar for the breast cancer and comparison groups. Nocturnal awakenings were excessive (9.2 versus 7.3). Mean sleep onset latency was longer for the breast cancer group than for the comparison group (34.8 versus 15.6 minutes). Mean insomnia severity scores for the breast cancer group indicated subthreshold insomnia symptoms, and no clinically significant insomnia for the comparison group (8.9 versus 6.4). Mean daytime sleepiness scores were normal for both groups (7 versus 6).
Conclusions: Subjective sleep quality was predicted by depressed mood only. Sleep in the breast cancer group was characterized by poor sleep quality, frequent nocturnal awakenings, and insomnia symptoms.
Implications for Nursing: Screening and monitoring in women aged 50 and older with breast cancer may help promote early sleep intervention; however, additional collaborative research regarding the underlying causes of sleep disruption is needed.
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